QBank Fortnightly Newsletter (Vol: 1, Issue: 7)

Updates from Robbins latest edition, COVID-19 updates by MOHFW and FDA approval

Hello! 

In our 7th issue, we bring you, yet again, a plethora of interesting updates and updated MCQs from the world of Qbank. 

To find the relevant MCQs, copy the MCQ IDs given under each topic and search for them in the Marrow app.

Take a look.  

1. Polycythemia Paraganglioma Syndrome 

MCQ ID: MD5107

Polycythemia Paraganglioma Syndrome, a catecholamine secreting extra-renal neuroendocrine tumour. It has been added to the list of familial syndromes associated with pheochromocytoma and extra-adrenal paragangliomas.

Refernce: Robbins Cotran Pathologic Basis of Disease 10th e – Table24.11

2. FELUDA for COVID-19

MCQ ID: MD5116

FNCAS9 Editor Linked Uniform Detection Assay (FELUDA) is a highly sensitive and rapid modality based on Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) gene-editing technology. 

  • The Tata CRISPR test is the world’s first diagnostic test to deploy a specially adapted Cas9 protein to detect the virus causing COVID-19, successfully
  • It achieves accuracy levels of traditional RT-PCR tests with a quicker turn around time, less expensive equipment, and better ease of use. 
  • It has been recently approved by the Drugs Controller General of India as reported by the Council of Scientific and Industrial Research (CSIR), Ministry of Science and Technology, to aid diagnosis of SARS-CoV2.

Reference: https://www.csir.res.in/slider/dcgi-approves-commercial-launch-low-cost-covid-19-test-feluda

3. Dapagliflozin for heart failure

MCQ ID: MA1870

Dapagliflozin, an SGLT-2 inhibitor, has been approved by the FDA for heart failure patients with reduced ejection fraction regardless of their diabetic status.

Reference: https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-type-heart-failure

4. Update on MMR in India

MCQ ID: MC4447

According to the special bulletin on Maternal Mortality in India ( 2016-18) released by the Office of the Registrar General’s Sample Registration System (SRS), the Maternal Mortality Ratio (MMR) in India has declined to 113 in 2016-18 from 122 in 2015-17 and 130 in 2014-2016.

Reference: https://censusindia.gov.in/vital_statistics/SRS_Bulletins/MMR%20Bulletin%202016-18.pdf

5. Revised guidelines for home isolation of COVID-19 cases and guidelines for home quarantine of contacts

MCQ IDs: MC4159, MD5109

Home isolation is recommended for very mild cases/ pre-symptomatic cases of COVID-19 for 17 days starting from the onset of symptoms. The patient should not have a fever for the last ten days of home isolation. There is no need for testing after the home isolation period is over.

 Eligibility for home isolation:

  •  A person should be clinically assigned as a very mild case/ pre-symptomatic case.
  • Such a person should have the requisite facility at their residence for self-isolation.
  • A caregiver should be available round the clock.
  • The caregiver and all close contacts of such cases should take Hydroxychloroquine prophylaxis.
  • Arogya Setu App must be used.
  • The patient shall agree to monitor his health and regularly inform his health status to the District Surveillance Officer.

 The person should seek immediate medical attention if serious signs or symptoms develop such as: 

  •  Difficulty in breathing.
  • Persistent pain/pressure in the chest.
  • Mental confusion or inability to arouse.
  • Developing bluish discolourations of lips/face.

Home quarantine applies to all contacts of a suspect or confirmed case of COVID-19. The home quarantine period is for 14 days from the day of contact with a confirmed or suspected case. If symptoms appear (cough/fever/difficulty in breathing), he/she should immediately inform the nearest health centre.

 A contact in the context of COVID-19 is:

  •  A person living in the same household as a COVID-19 case.
  • A person having had direct physical contact with a COVID-19 case or his/her infectious secretions without recommended personal protective equipment (PPE) or with a possible breach of PPE.
  • A person who has a face to face contact with a COVID-19 case or in a closed environment within 1 meter (including air travel)

References: https://www.mohfw.gov.in/pdf/RevisedguidelinesforHomeIsolationofverymildpresymptomaticCOVID19cases10May2020.pdf & https://www.mohfw.gov.in/pdf/Guidelinesforhomequarantine.pdf 

6. Advisory on strategy for COVID-19 testing in India as recommended by the national task force on COVID-19

MCQ ID: MD5110

  • Situations where Rapid Antigen Test (RAT) is recommended as the first line:
    • Routine surveillance in containment zones and screening at points of entry
    • All symptomatic cases, including health care workers and frontline workers.
    • All asymptomatic direct and high-risk contacts such as individuals in family and workplace, age ≥ 65 years, immunocompromised, those with comorbidities of a laboratory-confirmed case to be tested once between day five and day ten of coming into contact.
  • All asymptomatic high-risk individuals such as individuals with age ≥ 65 years, comorbidities in containment zones.
  •  Situations where RT-PCR or TrueNat or CBNAAT is recommended as the first line:
    • Routine surveillance in non-containment areas.
    • All symptomatic individuals with a history of international travel in the last 14 days.
    • All symptomatic contacts of a laboratory-confirmed case.
    • All symptomatic health care workers/frontline workers are involved in containment and mitigation activities. 
    • All patients with Severe Acute Respiratory Infection (SARI). 
    • Asymptomatic high-risk patients who are hospitalized or seeking immediate hospitalization.
    • All pregnant women in/near labour who are hospitalized for delivery.
    • All symptomatic neonates presenting with acute respiratory/sepsis-like illness. 
    • Patients presenting with atypical manifestations.

Algorithm for COVID-19 test interpretation using Rapid Antigen Test

Reference: https://www.mohfw.gov.in/pdf/AdvisoryonstrategyforCOVID19TestinginIndia.pdf 


Get the latest updated QBank MCQs from the Marrow Facebook page. ‘Like’ us by clicking hereOne MCQ every day.

To see the previous issues of the newsletter, click here

Share on Whatsapp
Share

79 Responses

  1. Shailendra says:

    Nice

  2. Archana says:

    Thank you marrow

  3. Dr.Sindhura says:

    Thankyou Marrow

  4. Naveen raj says:

    Thank u marrow…😍😍

  5. Anil says:

    Really great job by marrow
    ❤️❤️❤️

  6. Juhaina says:

    Great info on updated thankyou MarroW

  7. Juhaina says:

    Great info on updated

  8. Mahira Zaheer says:

    Thank you marrow

  9. Dr. Chandreyee Das says:

    Thanks a lot, Marrow.😃

  10. Dr. Priya says:

    Marrow U r the BEST ❤! Thank u!

  11. Ankita Patel says:

    Thank u Marrow.

  12. Ankita Patel says:

    Thank u Marrow.
    For this amazing updates

  13. Janki sonagra says:

    Thank you so much Marrow!!😊

  14. Darvin says:

    Thank you marrow!

  15. Neeshu says:

    How can I download this???

  16. Shweta says:

    How to download as a pdf.

  17. Ganesh koramoni says:

    Thank u 🙏 marrow

  18. Nimesh Patel says:

    Thanks MARROW

  19. Krinal says:

    Thank you

  20. Thanks MARROW for giving the updates …..

  21. Deepshikha says:

    How ti look previous one

  22. Rahul Singh sikarwar says:

    Thanks for amazing bucket of recent

  23. Vineeta rai says:

    How to save it for revising again

  24. Rithik says:

    ❤❤❤❤Thanks for the Kind Information!! REALLY HELPFUL

  25. Spoorthy says:

    Thank you marrow

  26. Gaurav says:

    Thankyou marrow

  27. Thank you so much marrow! Very informative.

  28. Shambhu kumar says:

    Thanks Marrow for giving such fruitful information.

  29. Anjali garg says:

    Thanxx

  30. Gaurav says:

    Thankyou for this marrow

  31. Dr manish says:

    Useful

  32. Vibhor says:

    Thank You Marrow

  33. Shashi says:

    It’s quite helpful

  34. Shashi says:

    It’s quite helpful and out of myth

  35. Shreya Agarwal says:

    THANKYOU marrow

  36. Dr. Rodgire Sujata says:

    Thanks marrow ! : )

  37. Deepika Meher says:

    Thanks for the update

  38. Jayasudha says:

    Thanq marrow

  39. Dr strange says:

    U are. So good marrow can u please provide us inicet model test

  40. Rachel Green says:

    Thanks

  41. Umang says:

    Naicee…

  42. Dr Baahu says:

    Thank you very much for the information, team Marrow!

    Jai maahishmathi ✊

  43. Kbs laxmi says:

    Thank u marrow

  44. Ravisuthan Kannan says:

    Thank you marrow

  45. Lavanya says:

    Nice & tq

  46. Shailendra says:

    Thanku marrow faculty

  47. Kavita sant says:

    Needful information … Thnks to you marrow

  48. Shruthi says:

    Thank u marrow

  49. Gaurav says:

    Thanksir

  50. Santoshi says:

    Thank you marrow

  51. Sravs says:

    Thank you marrow

  52. Yogesh shinde says:

    Thanks sir

  53. Dr swetanshu says:

    Thanks to marrow

  54. Dr swetanshu says:

    Thanku to marrow♥️ ..to updated us…time to time…
    Love ur efforts…and hard work..
    It’s our turn to make u proud

  55. dhineshsdk91@gmail.com says:

    Good , much use full updates

  56. Archana kondeti says:

    Thank you so much marrow

  57. Divya says:

    Thanks marrow 👍👍

  58. Kavz says:

    Love u marr6

  59. Dr dharam says:

    👍🙂

  60. Dr Raquif akhtar says:

    Thanks for a fruitful knowledge

  61. Dr.Mukul Kanojia says:

    Thanks team marrow

  62. Dr vinayak says:

    Thank u marrow

Leave a Reply

Your email address will not be published. Required fields are marked *